Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.880
+0.100 (12.82%)
At close: Mar 6, 2026, 4:00 PM EST
0.840
-0.040 (-4.53%)
After-hours: Mar 6, 2026, 6:55 PM EST
Immuron Employees
Immuron had 7 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$712,477
Profits / Employee
-$442,735
Market Cap
6.88M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 7 | 0 | - |
| Jun 30, 2024 | 7 | 1 | 16.67% |
| Jun 30, 2023 | 6 | 1 | 20.00% |
| Jun 30, 2022 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| Theriva Biologics | 22 |
| Kiora Pharmaceuticals | 12 |
| XTL Biopharmaceuticals | 10 |
| Alzamend Neuro | 7 |
| Mustang Bio | 6 |
| Can-Fite BioPharma | 5 |
| Creative Medical Technology Holdings | 4 |
IMRN News
- 2 days ago - Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target - Accesswire
- 6 weeks ago - Immuron Limited (IMRN) Presents at Emerging Growth Conference 89 - Slideshow - Seeking Alpha
- 6 weeks ago - Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target - Accesswire
- 6 weeks ago - Immuron Reports Continued Sales Growth - GlobeNewsWire
- 3 months ago - Immuron (IMRN) Collaborates on Vaccine Research with US Military Institutes - GuruFocus
- 4 months ago - Immuron (IMRN) Secures FDA Approval for Phase 2 Trial of IMM-529 - GuruFocus
- 4 months ago - Immuron: FDA Approves IND Application For IMM-529 - Nasdaq
- 4 months ago - Immuron IMM-529 IND approved by FDA - GlobeNewsWire